Anne-Sophie de Faucigny
Public Communications Contact at GETLINK SE
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jacques Gounon | M | 71 | 17 years | |
| Claire Piccolin | F | 61 | 22 years | |
| Deborah Merrens | F | 57 | 4 years | |
| Corinne Bach | F | 49 | 8 years | |
| Brune Poirson | M | 42 | 2 years | |
| Peter Ricketts | M | 71 | 2 years | |
| Yann Leriche | M | 50 | 4 years | |
| Sharon Flood | F | 59 | 4 years | |
| Bertrand Badré | M | 54 | 7 years | |
| Jean-Marc Janaillac | M | 71 | 4 years | |
| Steven Moore | M | - | - | |
| John Keefe | M | 62 | 4 years | |
| Guillaume Rault | M | - | 3 years | |
| Mark Cornwall | M | 54 | 3 years | |
| Laetitia Brun | F | 41 | 3 years | |
| Jean-Xavier Gaillat | M | - |
Yposkesi
 Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | 5 years |
| Morad El Gueddari | M | - |
Yposkesi
Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | 6 years |
| Jean Mouton | M | 68 | - | |
| Stéphane Sauvage | M | 56 | 26 years | |
| Philippe Vanderbec | M | 55 | 6 years | |
| Michel Boudoussier | M | - | - | |
| Michael Schuller | M | 62 | 22 years | |
| Elisabetta de Bernardi di Valserra | F | 47 | 6 years | |
| Benoît de Ruffray | M | 57 | 1 years | |
| Marie Lemarié | F | 52 | - | |
| Géraldine Périchon | F | 43 | 4 years | |
| Raphaël Doutrebente | M | - | - | |
| Jean-Baptiste Roussille | M | 53 | - | |
| Jean Pasternak | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Maxime Cordonnier | M | - |
Yposkesi
Yposkesi BiotechnologyHealth Technology Part of SK, Inc., Yposkesi is a French-based CDMO that offers bioprocess development and CGMP manufacturing services for AAV and lentiviral vector production. The company is based in Corbeil-Essonnes, France. The French company provides support for gene therapy and aims to provide the best and most complete viral vector solutions. Yposkesi provides flexibility to develop the best process for cell and gene therapy production and process for viral vector. The company was founded in 2015, and Alain Lamproye has been the CEO of the company since 2017. Yposkesi was acquired by SK Pharmteco, Inc. on March 31, 2021. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 30 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anne-Sophie de Faucigny
- Personal Network
